Stocktoria
Tonix Pharmaceuticals Holding Corp. TNXP
Tonix Pharmaceuticals Holding Corp. statistics & valuation
Market cap$210.7M
P / S16.1×
P / B0.9×
Net margin-946.2%
Return on equity-50.6%
FCF margin-787.5%
Return on capital-51%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -959.1% | -1354.3% | -1523.9% | — | — | — | — | — | — | — |
| Net margin | -946.2% | -1288.3% | -1501.8% | — | — | — | — | — | — | — |
| FCF margin | -787.5% | -604.8% | -1414.8% | — | — | — | — | — | — | — |
| Return on assets | -44.7% | -79.8% | -75.5% | -48.8% | -38.3% | -51.4% | -196.6% | -99.1% | -79.0% | -141.2% |
| Return on equity | -50.6% | -93.2% | -110.6% | -53.2% | -42.2% | -57.6% | -303.9% | -110.2% | -85.8% | -153.2% |
| Debt / equity | — | 0.06× | 0.10× | — | — | — | — | — | — | — |
| Current ratio | 7.42 | 6.50 | 2.53 | 7.19 | 8.71 | 8.96 | 2.72 | 9.81 | 12.44 | 12.83 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.